Merck and BGI Collaborating on Biomarker Discovery, Development of Genomic Technologies | GenomeWeb

Merck and China's BGI said this week that they are collaborating to discover and characterize diagnostic and drug development biomarkers "across a wide range of therapeutic areas" and to develop genomic technologies.

Both partners will propose projects and provide resources, expertise, samples, and other research material to conduct them.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.